Otsuka Corp reports higher first-quarter net profit

3 articles · Updated · MarketWatch · Apr 30

For the quarter ended 31 March, net profit rose to Y16.69 billion from Y14.49 billion as revenue increased to Y344.75 billion from Y315.54 billion.
Operating profit climbed to Y23.51 billion from Y21.18 billion, while pretax profit increased to Y24.31 billion from Y21.85 billion.
Earnings per share rose to Y44.01 from Y38.22, with diluted earnings at Y43.83; the results were prepared under Japanese accounting standards.

Why does Otsuka forecast a profit decline for 2026 despite its record-breaking first quarter?

How will Japan's forecasted economic stagflation impact Otsuka's domestic growth strategy?

Can Otsuka's nutraceuticals business offset the risks from its highly regulated pharmaceutical division?

Can Otsuka's R&D pipeline outpace Japan's aggressive new drug price cuts?

Will Otsuka's revolutionary no-immunosuppressant diabetes therapy reach patients before competitors?